TEST:

CancerSCAN

CancerSCAN is a cancer genome diagnosis solution for anticancer therapy that is customized to individuals, developed for the first time in Korea as a product of joint research with the clinicians at the Samsung Genome Research Center. It is based on NGS technology that accurately detects the diverse types of patient specimen mutations accurately and predicts patient prognosis through a database by selecting an optimal targeted anticancer agent and immuno-oncology most appropriate for the patient via a panel developed on the basis of several years of clinical experience.